C07D 491/048
The oxygen-containing ring being five-membered
Official title: the oxygen-containing ring being five-membered
C07D491/048 (The oxygen-containing ring being five-membered) appears on 1,460 US grants and 2,384 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,460
- Published applications
- 2,384
- Assignees
- 803
- Inventors
- 6,448
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 2 |
| 2003 | 1 | 2 |
| 2004 | 2 | 2 |
| 2005 | 0 | 8 |
| 2006 | 4 | 10 |
| 2007 | 1 | 15 |
| 2008 | 9 | 27 |
| 2009 | 11 | 26 |
| 2010 | 14 | 52 |
| 2011 | 25 | 68 |
| 2012 | 34 | 66 |
| 2013 | 72 | 89 |
| 2014 | 59 | 109 |
| 2015 | 76 | 117 |
| 2016 | 85 | 141 |
| 2017 | 107 | 139 |
| 2018 | 107 | 143 |
| 2019 | 110 | 142 |
| 2020 | 106 | 190 |
| 2021 | 109 | 142 |
| 2022 | 106 | 150 |
| 2023 | 106 | 228 |
| 2024 | 100 | 207 |
| 2025 | 126 | 183 |
| 2026 | 78 | 126 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Organic compound, light-emitting device, light-emitting apparatus, electronic appliance, and lighting device6 Oct 2026US 12,753,182 B2Semiconductor Energy Laboratory Co.Ltd.
- 1,5-disubstituted 1,2,3-triazoles are inhibitors of RAC/CDC42 GTPases6 Oct 2026US 12,753,183 B2University of Puerto Rico
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Organic molecules for use in light-emitting devices29 Sep 2026US 12,747,210 B2Samsung Display Co., Ltd.
- EIF4A-inhibiting compounds and methods related thereto29 Sep 2026US 12,747,249 B2SJP Biotec GmbH
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Crystalline forms of a parp1 inhibitor8 Oct 2026US 2026/0308163 A1Gilead Sciences, Inc.
- Compound containing oxo-pyrido-aliphatic ring or aliphatic heterocyclic structure, and medical use thereof8 Oct 2026US 2026/0308164 A1Sichuan Purity Pharmaceutical Co., Ltd.
- Cyclic vinyl sulfone wrn inhibitors1 Oct 2026US 2026/0297070 A1Nimbus Wadjet, Inc.
- Benzo-fused ring compound inhibitor, and preparation method therefor and use thereof1 Oct 2026US 2026/0297071 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Most cited
By later US patents
- N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors110US 8,716,303 B2Incyte Corporation · 2014
- Heteroaryl derivatives as CFTR modulators94US 8,299,099 B2Vertex Pharmaceuticals Incorporated · 2012
- Complement pathway modulators and uses thereof90US 9,056,874 B2Novartis AG · 2015
- AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases80US 7,560,434 B2BioCryst Pharmaceuticals, Inc. · 2009
- Therapeutic furopyrimidines and thienopyrimidines78US 7,429,571 B2BioCryst Pharmaceuticals, Inc. · 2008